Cargando…

Prevalence and associations of metabolic syndrome in patients with alcohol use disorder

Excessive alcohol consumption has been associated with different components of the metabolic syndrome (MetS) such as arterial hypertension, dyslipidemia, type 2 diabetes or obesity. We aimed to analyze the prevalence and associations of MetS in patients with Alcohol Use Disorder (AUD). Cross-section...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hernández-Rubio, Anna, Sanvisens, Arantza, Bolao, Ferran, Cachón-Suárez, Isabel, Garcia-Martín, Carme, Short, Antoni, Bataller, Ramón, Muga, Roberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850419/ https://www.ncbi.nlm.nih.gov/pubmed/35173187 http://dx.doi.org/10.1038/s41598-022-06010-3

Ejemplares similares

Association of hyperuricemia and gamma glutamyl transferase as a marker of metabolic risk in alcohol use disorder
por: Hernández-Rubio, Anna, et al.
Publicado: (2020)

Author Correction: Association of hyperuricemia and gamma glutamyl transferase as a marker of metabolic risk in alcohol use disorder
por: Hernández‑Rubio, Anna, et al.
Publicado: (2023)

Alcohol use disorder and its impact on chronic hepatitis C virus and human immunodeficiency virus infections
por: Fuster, Daniel, et al.
Publicado: (2016)

Hepatitis C infection substantially reduces survival of alcohol-dependent patients
por: Muga, Roberto, et al.
Publicado: (2018)

Markers of Inflammation and Mortality in a Cohort of Patients With Alcohol Dependence
por: Fuster, Daniel, et al.
Publicado: (2015)

Markers of Monocyte Activation, Inflammation, and Microbial Translocation Are Associated with Liver Fibrosis in Alcohol Use Disorder
por: Fuster, Daniel, et al.
Publicado: (2021)

Assessment of liver disease in patients with chronic hepatitis C and unhealthy alcohol use
por: Fuster, Daniel, et al.
Publicado: (2021)

Long-Term Outcomes of Patients With Cocaine Use Disorder: A 18-years Addiction Cohort Study
por: Sanvisens, Arantza, et al.
Publicado: (2021)

Unhealthy Alcohol Use, HIV Infection and Risk of Liver Fibrosis in Drug Users with Hepatitis C
por: Muga, Roberto, et al.
Publicado: (2012)

Alcohol Consumption during Pregnancy: Analysis of Two Direct Metabolites of Ethanol in Meconium
por: Sanvisens, Arantza, et al.
Publicado: (2016)

Monitoring hepatitis C virus treatment rates in an Opioid Treatment Program: A longitudinal study
por: Sanvisens, Arantza, et al.
Publicado: (2020)

Liver Enzyme Alterations in HCV-Monoinfected and HCV/HIV-Coinfected Patients
por: Langohr, Klaus, et al.
Publicado: (2008)

Sex-specific disease outcomes of HIV-positive and HIV-negative drug users admitted to an opioid substitution therapy program in Spain: a cohort study
por: Muga, Roberto, et al.
Publicado: (2014)

Differences in the Impact of COVID-19 on Pathology Laboratories and Cancer Diagnosis in Girona
por: Sanvisens, Arantza, et al.
Publicado: (2021)

Population-Based Analysis of Trends in Incidence and Survival of Human Papilloma Virus-Related Oropharyngeal Cancer in a Low-Burden Region of Southern Europe
por: Rubió-Casadevall, Jordi, et al.
Publicado: (2022)

Trends in the management and burden of alcoholic liver disease
por: Mathurin, Philippe, et al.
Publicado: (2015)

Genome-Scale Metabolic Modeling Reveals Sequential Dysregulation of Glutathione Metabolism in Livers from Patients with Alcoholic Hepatitis
por: Manchel, Alexandra, et al.
Publicado: (2022)

Overall and cause-specific mortality in HIV-positive subjects compared to the general population
por: Alejos, Belen, et al.
Publicado: (2014)

Epidemiology and Molecular Profile of Mucosal Melanoma: A Population-Based Study in Southern Europe
por: Carbó-Bagué, Anna, et al.
Publicado: (2022)

Management of alcohol use disorder in patients with cirrhosis in the setting of liver transplantation
por: Arab, Juan Pablo, et al.
Publicado: (2021)

Recent advances in alcoholic hepatitis
por: Rachakonda, Vikrant, et al.
Publicado: (2020)

Increased Natural Killer Cells Are Associated with Alcohol Liver Fibrosis and with T Cell and Cytotoxic Subpopulations Change
por: Zuluaga, Paola, et al.
Publicado: (2022)

Pathophysiology and Management of Alcoholic Liver Disease: Update 2016
por: Stickel, Felix, et al.
Publicado: (2017)

Erratum: Pathophysiology and Management of Alcoholic Liver Disease: Update 2016
por: Stickel, Felix, et al.
Publicado: (2017)

Serum Acylcarnitines Associated with High Short-Term Mortality in Patients with Alcoholic Hepatitis
por: Gao, Bei, et al.
Publicado: (2021)

Public health policies and alcohol-related liver disease
por: Ventura-Cots, Meritxell, et al.
Publicado: (2019)

Subclinical versus advanced forms of alcohol-related liver disease: Need for early detection
por: Gómez-Medina, Concepción, et al.
Publicado: (2023)

A rare case of unusual scar in atrial fibrillation ablation: The “Yin‐Yang” left atrium
por: Albarrán‐Rincón, Ramón, et al.
Publicado: (2022)

Bariatric Surgery Is Associated with Alcohol-Related Liver Disease and Psychiatric Disorders Associated with AUD
por: Alvarado-Tapias, Edilmar, et al.
Publicado: (2023)

Alcoholic hepatitis masquerading as tumor infiltration: Reversibility after abstinence
por: Gluskin, Adam B., et al.
Publicado: (2019)

Socioeconomic inequalities in the incidence of alcohol-related liver disease in the Latin American context
por: Roblero, Juan Pablo, et al.
Publicado: (2021)

The Role of Sphingolipids Metabolism in Cancer Drug Resistance
por: Bataller, Marina, et al.
Publicado: (2021)

Determinants of Cue-Elicited Alcohol Craving and Perceived Realism in Virtual Reality Environments among Patients with Alcohol Use Disorder
por: Hernández-Serrano, Olga, et al.
Publicado: (2021)

Alcohol treatment discussions and clinical outcomes among patients with alcohol-related cirrhosis
por: Alexandre, Wheytnie, et al.
Publicado: (2023)

Cardio-Metabolic Disorders in Non-Alcoholic Fatty Liver Disease
por: El Hadi, Hamza, et al.
Publicado: (2019)

Prevalence and clinical impact of alcohol withdrawal syndrome in alcohol-associated hepatitis and the potential role of prophylaxis: a multinational, retrospective cohort study
por: Marti-Aguado, David, et al.
Publicado: (2023)

Myeloid Endoplasmic Reticulum Resident Chaperone GP96 Facilitates Inflammation and Steatosis in Alcohol‐Associated Liver Disease
por: Ratna, Anuradha, et al.
Publicado: (2021)

Hepatic COX-2 expression protects mice from an alcohol-high fat diet-induced metabolic disorder by involving protein acetylation related energy metabolism
por: Chen, Minjie, et al.
Publicado: (2021)

Alcohol-Associated Liver Disease Mortality Increased From 2017 to 2020 and Accelerated During the COVID-19 Pandemic
por: Deutsch-Link, Sasha, et al.
Publicado: (2022)

Time trends and survival of marginal zone lymphoma over 25 years in Girona, Spain (1994–2018)
por: Auñón, Carmen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lsm8c3ljdg9gtvmt3q9k12c8vf